Gout and hyperuricaemia are two clinical situations associated with an elevated risk of
developing cardiovascular (heart failure, myocardial infarction, stroke) and metabolic and …

Gout: diagnosis and management—summary of NICE guidance | The BMJ Skip to main
content Intended for healthcare professionals Access provided by Google Indexer Subscribe …

Background Gout is the most prevalent inflammatory arthritis, yet one of the worst managed.
Our objective was to assess how the COVID-19 pandemic impacted incidence and quality of …

Objective The main objective of the study was to see the concordance between the
diagnosis of gout recorded in primary care electronic medical records and the ACR/EULAR …

Background Gout is associated with significant morbidity and mortality, yet suboptimal gout
control remains a problem globally. Identifying the risk factors associated with poor gout …

Objective To assess the proportion of, and factors associated with, older adults with gout
receiving a serum urate (SUA) test after starting urate‐lowering therapy (ULT). Methods We …

Medication adherence in gout is low, and discontinuation of urate-lowering therapy puts
patients at risk of flares and cardiovascular events. A strategy to regularly monitor serum …

Objectives We sought to evaluate urate lowering therapy (ULT) adherence and treatment‐to‐
target (T2T) serum uric acid (SUA) levels amongst older adults with gout starting ULT …

Objectives To determine the risk of adverse events associated with colchicine or non-
steroidal anti-inflammatory drug (NSAID) prophylaxis when initiating allopurinol for gout …

Objective To investigate the inter-relationships among genetic risk, healthy lifestyle
adherence, and hyperuricaemia susceptibility. Methods This prospective cohort study was …